Viewing Study NCT00216957



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00216957
Status: COMPLETED
Last Update Posted: 2005-09-22
First Post: 2005-09-19

Brief Title: Randomized Clinical Trial Comparing Coronary Bypass Grafting With or Without Cardiopulmonary Bypass
Sponsor: Maritime Heart Centre
Organization: Maritime Heart Centre

Study Overview

Official Title: Randomized Clinical Trial Comparing Coronary Bypass Grafting With or Without Cardiopulmonary Bypass
Status: COMPLETED
Status Verified Date: 2005-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Coronary artery bypass grafting CABG is a well established treatment modality for patients with coronary artery disease For 30 years now CABG operations have been performed with the help of the heart lung machine Cardiopulmonary bypass However the heart lung machine is believed to be responsible for many of the side effects and complications seen in patients following CABG surgery The organs most commonly affected are the brain blood constituents lungs and kidneys

In the last few years stabilising devices have been developed that allow CABG operations to be performed safely without the use of the heart lung machine Our hypothesis was that CABG done without the heart lung machine may be better tolerated by patients resulting in lower morbidity increased functional outcome and shorter hospital length of stay

Enrolment into the trial was from 1998 to 2003 and included 300 patients The last patient was enrolled in June of 2003 The initial results from the study suggest that excellent results can be obtained with both techniques and contrary to others no advantages could be demonstrated in in-hospital outcomes of patients performed without cardiopulmonary bypass Legare et al Circulation 2005
Detailed Description: We are now in follow-up to evaluate the medium term and long term outcomes of all 300 patients originally enrolled in above mentioned randomized clinical trial The follow-up of patients is approved by the Capital Health Research Ethics Board CDHA-RS2004-295

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None